83
Participants
Start Date
September 21, 2016
Primary Completion Date
August 22, 2017
Study Completion Date
September 20, 2017
GS-9876
One tablet administered orally once daily
Filgotinib
Two tablets administered orally once daily
GS-9876 placebo
One tablet administered orally once daily
Filgotinib placebo
Two tablets administered orally once daily
Methotrexate
Background therapy with methotrexate administered orally or parenterally once weekly
NMTH Tsar Boris III, Sofia
Medical Center_Clinic of International Institute of clinical Studies, Kyiv
MHAT-Plovdiv AD, Plovdiv
Umhat Kaspela, Plovdiv
Altoona Center for Clinical Research, Duncansville
Medical Associates of North Georgia, Canton
A-Shine s.r.o., Pilsen
Omega Research Consultants, DeBary
Sarasota Arthritis Research Center, Sarasota
Center For Arthritis and Osteoporosis, Elizabethtown
Medical Plus, S.R.O., Uherské Hradiště
Accurate Clinical Management - Najam, Houston
Accurate Clinical Research Inc., Stafford
Medical Center Research LLC, Webster
Albuquerque Center For Rheumatology, Albuquerque
Kharkiv City Hospital 8, Kharkiv
LLC Arensia Exploratory Medicine, T'bilisi
ARENSIA Exploratory Medicine Phase I Unit, Republican Clinical Hospital, Chisinau
ClinicMed Badurski i wspolnicy Spolka Jawna, Bialystok
Lead Sponsor
Gilead Sciences
INDUSTRY